Investing.comCodex · 实盘不做把握 3/10
北京时间·🕒 发布 19:36:35时区推断·⟳ 抓取 19:38:19·⚡ 决策 07-28 19:42:50 +4m31s·91.5 天前
3D Systems协助Walter Reed获得首个院内制造钛颅骨板FDA 510(k)许可
该事件是3D Systems为Walter Reed/Defense Health Agency提供质量体系、设计验证、增材制造流程和监管策略支持，方向上验证其医疗3D打印能力。
📄 原文Investing.com↗ 原文
3D Systems helps Walter Reed achieve first FDA-cleared implant
Oil extends slide as U.S.-Iran talks raise hopes of lasting de-escalation ROCK HILL, S.C. - 3D Systems (NYSE:DDD) annou…
不做 3D Systems（DDD.US）
未披露金额和采购承诺，许可主体也不是3D Systems自有可规模化产品获批；对DDD.US短线收入/利润传导太小，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-28 · 扩散 low · price-in 风险 medium ↗
关键理由
- 该事件是3D Systems为Walter Reed/Defense Health Agency提供质量体系、设计验证、增材制造流程和监管策略支持，方向上验证其医疗3D打印能力。
- 许可主体是Walter Reed的3D Medical Applications Center而非3D Systems自有大规模商业产品获批，且未披露订单、收入分成、采购承诺或可量化装机扩张。
- 用于军方创伤性颅骨修复的个性化钛板场景较窄，短线难以证明会显著改变3D Systems收入或利润预期。
主要风险
- 若后续披露Defense Health Agency或VA系统性采购合同、金额和3D Systems经济权益，需按订单/供货事件重新评估。
- 当前仅为公司新闻稿式合作成果披露，容易被市场视作品牌背书而非业绩催化。
原文全文
展开原文 · 2,019 字
Oil extends slide as U.S.-Iran talks raise hopes of lasting de-escalation
ROCK HILL, S.C. - 3D Systems (NYSE:DDD) announced today that it supported the Defense Health Agency and Walter Reed National Military Medical Center’s 3D Medical Applications Center in obtaining FDA premarket clearance for a titanium cranial plate system, marking the first FDA-cleared implant granted to a point-of-care institution.
The 3D MAC Titanium Cranial Plate System will be used to treat U.S. active duty personnel and war fighters with traumatic head injuries. The clearance represents the culmination of a multi-year collaboration between 3D Systems and 3D MAC, according to a press release statement.
3D Systems worked with 3D MAC to establish a quality management system and provided support throughout the development lifecycle, from design and validation through regulatory submission. The company provided expertise in process controls, device design optimization, additive manufacturing workflows, and regulatory strategy.
"We believe point-of-care manufacturing is transforming the future of healthcare by bringing personalized medical devices closer to the patient," said Jeff Graves, President and CEO of 3D Systems.
The 3D Medical Applications Center, based at Walter Reed National Military Medical Center, specializes in patient-specific anatomical models, surgical guides, and implants for service members and veterans.
The clearance marks 3D MAC’s first FDA-cleared medical device. Natalie Byrnes, Manager of Product Development for Patient Specific Medical Technology at 3D Systems, said the clearance demonstrates the combination of clinical innovation with expertise in additive manufacturing and regulatory compliance.
3D Systems maintains collaborations with the U.S. Defense Health Agency and the Department of Veterans Affairs. The clearance is listed on the FDA website under submission number K253116.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
ROCK HILL, S.C. - 3D Systems (NYSE:DDD) announced today that it supported the Defense Health Agency and Walter Reed National Military Medical Center’s 3D Medical Applications Center in obtaining FDA premarket clearance for a titanium cranial plate system, marking the first FDA-cleared implant granted to a point-of-care institution.
The 3D MAC Titanium Cranial Plate System will be used to treat U.S. active duty personnel and war fighters with traumatic head injuries. The clearance represents the culmination of a multi-year collaboration between 3D Systems and 3D MAC, according to a press release statement.
3D Systems worked with 3D MAC to establish a quality management system and provided support throughout the development lifecycle, from design and validation through regulatory submission. The company provided expertise in process controls, device design optimization, additive manufacturing workflows, and regulatory strategy.
"We believe point-of-care manufacturing is transforming the future of healthcare by bringing personalized medical devices closer to the patient," said Jeff Graves, President and CEO of 3D Systems.
The 3D Medical Applications Center, based at Walter Reed National Military Medical Center, specializes in patient-specific anatomical models, surgical guides, and implants for service members and veterans.
The clearance marks 3D MAC’s first FDA-cleared medical device. Natalie Byrnes, Manager of Product Development for Patient Specific Medical Technology at 3D Systems, said the clearance demonstrates the combination of clinical innovation with expertise in additive manufacturing and regulatory compliance.
3D Systems maintains collaborations with the U.S. Defense Health Agency and the Department of Veterans Affairs. The clearance is listed on the FDA website under submission number K253116.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。